Skip to main content

Miromatrix Medical, Inc. (MIRO)

NASDAQ: MIRO · Delayed Price · USD
7.00
+0.14 (2.04%)
After-hours:Sep 17, 2021 7:42 PM EDT
6.86
-0.89 (-11.48%)
At close: Sep 17, 4:00 PM
Market Cap137.55M
Revenue (ttm)41,295
Net Income (ttm)n/a
Shares Out2.91M
EPS (ttm)-3.45
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume88,544
Open7.73
Previous Close7.75
Day's Range6.86 - 8.29
52-Week Range6.86 - 16.52
Betan/a
Analystsn/a
Price Target22.00 (+220.7%)
Est. Earnings Daten/a

About MIRO

Miromatrix Medical is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients’ lives. We have developed a proprietary perfusion technology platform for bioengineering organs that we believe will efficiently scale to address the shortage of available human organs. Our perfusion decellularization and recellularization technology platform includes 118 issued and 35 pending patent applications, with protection in the United States and major markets worldwide. Our...

IndustryBiotechnology
IPO DateJun 24, 2021
CEOJeff Ross
Employees36
Stock ExchangeNASDAQ
Ticker SymbolMIRO
Full Company Profile

Financial Performance

In 2020, MIRO's revenue was $46,530, a decrease of -81.39% compared to the previous year's $250,000. Losses were -$10.31 million, 154.8% more than in 2019.

Financial Statements

News

Miromatrix Announces Key Strategic Investors to Advance the Development of Bioengineered Livers and Kidneys

The biotechnology company working to eliminate the organ transplant waitlist outlines expansion of its clinical work, supported by IPO funds and Series C round, led by Baxter, CareDx, and DaVita The bio...

1 month ago - GlobeNewsWire

Miromatrix Medical Announces Closing of Initial Public Offering

EDEN PRAIRIE, Minn., June 28, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (Nasdaq: MIRO) ("Miromatrix"), a life sciences company pioneering a novel technology for bioengineering fully transplantabl...

2 months ago - GlobeNewsWire

Miromatrix Medical Announces Pricing of Upsized Initial Public Offering

EDEN PRAIRIE, Minn., June 24, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (Nasdaq: MIRO) ("Miromatrix"), a life sciences company pioneering a novel technology for bioengineering fully transplantabl...

2 months ago - GlobeNewsWire

Miromatrix Medical IPO Registration Document (S-1)

Miromatrix Medical, Inc. has filed to go public with an IPO on the NASDAQ.

3 months ago - SEC